RxDoctor Payments Data

Carri Myers

Psychiatric/Mental Health · Decatur, MSNPI 1760905004

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2024 at $1,391 and has fallen 77.3% since, to $316 in 2025. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,337in general payments, 2019–2025

Across 247 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$460
  • Takeda Pharmaceuticals U.S.A., Inc.$448
  • Vanda Pharmaceuticals Inc.$313
  • Axsome Therapeutics, Inc.$306
  • Teva Pharmaceuticals USA, Inc.$276
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,28899%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,337 in reported general payments places this provider in the 90th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$5,972
Medicare patients
19
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine28$1,294
Buprenorphine Hcl13$1,053
Duloxetine Hcl14$617
Fluoxetine Hcl45$453
Buspirone Hcl19$270
Escitalopram Oxalate20$265
Hydroxyzine Hcl20$253
Aripiprazole13$202
Alprazolam46$164
Trazodone Hcl16$157
Mirtazapine15$136
Benztropine Mesylate11$135
Hydroxyzine Pamoate12$118
Bupropion XlBupropion Hcl12$72
Risperidone12$41

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Decatur

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →